Literature DB >> 1682967

Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia: one-year followup study.

J A Sweeney1, G L Haas, J G Keilp, M Long.   

Abstract

Few studies have evaluated the longitudinal stability of neuropsychological deficits in schizophrenia. In the present study, 39 inpatients with DSM-III-R schizophrenia were administered a comprehensive battery of neuropsychological tests after achieving sufficient clinical recovery to warrant discharge, and again 1 year after the first assessment during a nonacute period. Significant improvement in neuropsychological functioning from the first to the second assessment was observed on several tasks, including the following: Trails A and B, Digit Symbol, Judgment of Line Orientation, recognition memory on the Rey Auditory Verbal Learning Test, the Wisconsin Card Sort, and Finger Tapping. These improvements were unrelated to treatment history, and were similar in first episode and chronic cases. For many patients, the improvement in functioning brought test performance into line with normative scores from test standardization samples. These results indicate that considerable improvement in neuropsychological functioning can occur in schizophrenic patients over the months following an acute episode of illness, and that recovery of cognitive functioning can occur after substantial clinical recovery from an acute episode of illness has already been achieved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682967     DOI: 10.1016/0165-1781(91)90053-r

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

Review 1.  Measuring neuropsychological change in schizophrenia with novel antipsychotic medications.

Authors:  S E Purdon
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 2.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

3.  Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study.

Authors:  D M Censits; J D Ragland; R C Gur; R E Gur
Journal:  Schizophr Res       Date:  1997-04-11       Impact factor: 4.939

4.  Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?

Authors:  Rozmin Halari; Ravi Mehrotra; Tonmoy Sharma; Veena Kumari
Journal:  Schizophr Bull       Date:  2006-06-07       Impact factor: 9.306

5.  Neurodevelopmental theories of schizophernia : application to late-onset schizophernia.

Authors:  B W Palmer; D V Jeste
Journal:  Indian J Psychiatry       Date:  1996-01       Impact factor: 1.759

Review 6.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

Review 7.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

8.  Cognitive factors for predicting treatment response in schizophrenic patients: one-year follow-up study.

Authors:  Yong-Ku Kim; Ae-Ra Lee; Ji-Won Hur; Ho-Kyung Yoon; Bun-Hee Lee; Young-Hoon Ko
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

9.  Relational Memory in the Early Stage of Psychosis: A 2-Year Follow-up Study.

Authors:  Suzanne N Avery; Kristan Armstrong; Maureen McHugo; Simon Vandekar; Jennifer Urbano Blackford; Neil D Woodward; Stephan Heckers
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

10.  Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.

Authors:  Seenae Eum; S Kristian Hill; Ney Alliey-Rodriguez; James M Stevenson; Leah H Rubin; Adam M Lee; Lauren J Mills; James L Reilly; Rebekka Lencer; Sarah K Keedy; Elena Ivleva; Richard S E Keefe; Godfrey D Pearlson; Brett A Clementz; Carol A Tamminga; Matcheri S Keshavan; Elliot S Gershon; John A Sweeney; Jeffrey R Bishop
Journal:  Neuropsychopharmacology       Date:  2021-06-18       Impact factor: 8.294

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.